ACAD

ACADIA Pharmaceuticals Inc.

About ACAD

Acadia Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops and commercializes novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The Company’s pipeline product candidates in CNS areas includes NUPLAZID (pimavanser), Trofinetide, ACP-044 and ACP-319. NUPLAZID (pimavanserin) is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis (PDP). ACP-044, is an orally administered, non-opioid analgesic being evaluated for the treatment of pain. The Company has initiated a Phase II study evaluating ACP-044 for the treatment of postoperative pain following bunionectomy surgery. The Company also initiated an additional Phase II study evaluating ACP-044 for the treatment of pain associated with osteoarthritis. ACP-319 is a positive allosteric modulator of the muscarinic receptor targeting M1 (M1 PAM).

Buy US stocks in Australia starting with ACAD. Open an account and start investing today!

Market Capitalisation

$3.21B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.09M

High today

$20.03

Low today

$19.73

Open price

$19.75

52-week high

$28.06

52-week low

$12.24

ACAD FAQs

How much is one share of ACADIA Pharmaceuticals Inc.?

One share of ACADIA Pharmaceuticals Inc. is valued at $19.85.

What is the ticker symbol for ACADIA Pharmaceuticals Inc.?

The ticker symbol for ACADIA Pharmaceuticals Inc. is ACAD.

How do I buy ACAD shares in Australia?

To buy ACAD stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ACAD

What is the market capitalisation of ACADIA Pharmaceuticals Inc. ACAD?

As of 07/02/2023 ACADIA Pharmaceuticals Inc. has a market cap of $3.2B.

What is the 52-week high for ACADIA Pharmaceuticals Inc. stock?

The ACADIA Pharmaceuticals Inc. 52-week high stock price is $28.06.

What is the 52-week low for ACADIA Pharmaceuticals Inc. stock?

The ACADIA Pharmaceuticals Inc. 52-week low stock price is $12.24.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.